EP17.13: CVRI as a quick method to estimate peripheral vascular resistance at 13–16 weeks of gestation in patients at high risk of pre‐eclampsia

Documenti analoghi

• EP16.34: Placental cysts and atypical placental sonolucencies at 11–13 weeks of gestation: sonographic features and clinical significance
  di: W. Sepulveda
  Pubblicazione: (2024)
• EP17.15: Evaluation of clinical and biophysical markers as a screening test for late‐onset pre‐eclampsia between 35 and 38 weeks of gestation
  di: M. Parra‐Cordero, et al.
  Pubblicazione: (2024)
• Placental growth factor for pre‐eclampsia screening before 11 weeks' gestation
  di: R. López‐Mármol, et al.
  Pubblicazione: (2026)
• OC13.05: Developing pre‐eclampsia: does gestational age matter?
  di: C. Haavaldsen, et al.
  Pubblicazione: (2024)
• OP13.01: *Effective aspirin treatment for women at risk of pre‐eclampsia delays the metabolic clock of gestation
  di: L. Nguyen Hoang, et al.
  Pubblicazione: (2024)